OpenNashEarnings

Raffles Medical Group (BSL) · Health Care

Raffles Medical Group FY2025 earnings: summary, key numbers & outlook

Results filed 23 Feb 2026 · Quarter ended 31 Dec 2025

Press release ↗Investor relations ↗

Summaries and transcripts are machine-generated and can contain errors.

In brief

Raffles Medical Group marked its 50th year by preparing a healthy longevity centre, a compliant insurance rider and AI adoption, while China and integrated care drive expansion across 14 Asian cities.

Raffles Medical Group grew through higher patient volumes and larger average bills in its hospitals in Singapore and China. Its China business gained from cost efficiency and partnerships with Shanghai's Renji Hospital and Chongqing's First Affiliated Hospital. RafflesHealthinsurance added new contracts and repriced existing ones while managing claims tightly. The group serves more than 2.8 million patients across four hospitals and over 100 clinics.

Management plans to grow services for ageing populations in Singapore and China, expand across the 14 cities where it operates, and look for earnings-accretive assets in Asia Pacific. A physician-led RafflesHealthyLongevityCentre is due in Q1 2026, and the group intends to adopt AI early. The tension is regulatory: Singapore's higher co-payment cap forces a new insurance rider, though management expects little financial impact.

Key numbers

Revenue · GAAP
S$765.3 million

up 1.8% from a year ago

PATMI · GAAP
S$70.6 million

up 13.4% from a year ago

Diluted EPS · GAAP
3.81 cents

up 14.1% from a year ago

Operating profit · GAAP
90.4M

up 9.5% from a year ago

Operating cash flow · GAAP
S$101.3 million

Cash and cash equivalents
S$310.8 million

Segment or metricValueChange
Hospital Services revenueS$357.8 millionup 3.5% year-on-year
Healthcare Services revenueS$285.9 million
RafflesHealthinsurance revenueS$185.2 millionup 4.1%
Where each number comes from
  • Revenue: “Group revenue for FY2025 rose 1.8% year-on-year to S$765.3 million, underpinned by higher patient volumes, improved average bill sizes and operational efficiencies.”
  • PATMI: “For FY2025, PATMI increased 13.4% to S$70.6 million, driven by improved performance from the Hospital Services and Insurance businesses”
  • Diluted EPS: “Diluted earnings per share increased 14.1% to 3.81 cents”
  • Operating profit: “Operating Profit 48.7 41.2 18.3 90.4 82.5 9.5 Profit After Tax 38.6 31.4 23.1 71.1 62.3 14.1”
  • Operating cash flow: “The Group generated operating cash flows of S$101.3 million in FY2025.”
  • Cash and cash equivalents: “Its balance sheet remained strong, with S$310.8 million in cash and cash equivalents as at 31 December 2025”
  • Hospital Services revenue: “The Hospital Services Division delivered strong growth, with revenue increasing 3.5% year-on-year to S$357.8 million and profit rising 15.3% to S$41.1 million.”
  • Healthcare Services revenue: “The Healthcare Services Division generated revenue of S$285.9 million, with profitability remaining broadly stable.”
  • RafflesHealthinsurance revenue: “RafflesHealthinsurance (RHI) recorded revenue growth of 4.1%, increasing from S$178.0 million in FY2024 to S$185.2 million in FY2025”

Copied from the press release ↗ and other documents in the company's results page ↗. A figure is published only if its sentence is in those documents.

Outlook

MetricPeriodOutlook
DividendFY20263.0 cents per share

Key takeaways

  1. Longevity centre opens in Q1 2026

    RafflesHealthyLongevityCentre is a physician-led, multidisciplinary service offering advanced diagnostics and evidence-based therapies. It extends the group into personalised preventive care.

  2. China hospitals gain from local partnerships

    RafflesChinaHealthcare is partnering with Shanghai's Renji Hospital and Chongqing's First Affiliated Hospital. Management says earlier cost efficiency initiatives improved the bottom line and position China for a growing contribution.

  3. Insurance arm adapts to new co-payment cap

    The Ministry of Health set a higher co-payment cap of at least S$6,000, and RHI will launch a compliant rider. Management does not expect a significant financial impact.

  4. Integrated care pairs hospitals with insurance

    RMG positions itself as an end-to-end provider of healthcare and insurance for individuals and corporates. RHI's growth came from contract repricing and new contracts.

  5. Management targets ageing demographics and AI

    The group plans to grow services in demand as Singapore and China age, and to be an early adopter of appropriate AI applications. It is also evaluating earnings-accretive assets in Asia Pacific.

Questions

What is Raffles Medical launching in 2026?

The RafflesHealthyLongevityCentre is scheduled to open in Q1 2026 as a physician-led, multidisciplinary preventive care service. RHI will also launch a new rider that complies with Singapore's higher co-payment cap.

How is the China business performing?

RafflesChinaHealthcare revenue rose 2.3% to CNY359.4 million, helped by cost efficiencies and partnerships with Renji Hospital and Chongqing's First Affiliated Hospital.

How will Singapore's new co-payment cap affect the insurance business?

MOH introduced a co-payment cap of a minimum of S$6,000, and RHI will launch a compliant rider. Management does not expect a significant impact on RHI's financials.

What is management's strategy for growth?

It plans to serve ageing populations in Singapore and China, expand services across 14 Asian cities, evaluate earnings-accretive Asia Pacific assets and adopt appropriate AI early.

What is the group's outlook for FY2026?

Based on current conditions and barring unforeseen circumstances, the Board is optimistic the group will remain profitable in FY2026. No numeric guidance was given.

Documents

Results documents